Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03770832 · ClinicalTrials.gov registry record
Wearable Sensors and Video Recordings to Monitor Motor Development
A clinical trial of Neurodevelopmental Disorders and Developmental Disability, sponsored by Shirley Ryan AbilityLab.
- Active
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT03770832: Active study of Neurodevelopmental Disorders and Developmental Disability, sponsored by Shirley Ryan AbilityLab.
NCT03770832 is a study of Neurodevelopmental Disorders and Developmental Disability that is active but no longer recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 150 participants, below the 576-participant average among 27 other Neurodevelopmental Disorders trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03770832, a study of Neurodevelopmental Disorders and Developmental Disability, is active but no longer recruiting, sponsored by Shirley Ryan AbilityLab.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this study is to develop an automated, precise, quantitative assay for detecting atypical motor behavior and development in infants using data from wearable sensors and video recordings.
Primary Outcome
Error between true clinical test scores and scores estimated from sensor and video data, assessed at the 3 month time-point.
Conditions Studied
Study Locations (2)
Illinois
- Shirley Ryan AbilityLab - Chicago
- University of Illinois at Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-03-29 |
| Est. Completion | 2026-12 |
What the registry record for NCT03770832 still lists
NCT03770832 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 576-participant average among 27 other Neurodevelopmental Disorders trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Neurodevelopmental Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT03770832 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03770832 about?
NCT03770832 is a clinical study titled "Wearable Sensors and Video Recordings to Monitor Motor Development". The objective of this study is to develop an automated, precise, quantitative assay for detecting atypical motor behavior and development in infants using data from wearable sensors and video recordings.
What is the current status of trial NCT03770832?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2019-03-29. Estimated completion is 2026-12.
What conditions does trial NCT03770832 study?
This clinical trial studies the following conditions: Neurodevelopmental Disorders, Developmental Disability, Motor Delay.
Who is sponsoring clinical trial NCT03770832?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03770832 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurodevelopmental Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03770832's enrollment target sits among peer trials
150 14th of 27 higher than 13 of 27 other Neurodevelopmental Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neurodevelopmental Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Motor-voice Assessment in Infants (MAMI)
RECRUITING
-
Natural History Study of GEMIN-5 Related Neurodevelopmental Disorder
RECRUITING
-
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI